Key Benefits

• See your inflammation–cholesterol balance in one number.
• Flag higher cardiovascular risk linked to neutrophil activity and low HDL.
• Clarify cardiometabolic risk beyond LDL by combining immune and lipid signals.
• Guide risk assessment intensity by prioritizing exercise, weight loss, sleep, and smoking cessation.
• Track progress as lifestyle changes raise HDL and lower inflammatory white cells.
• Identify metabolic stress consistent with insulin resistance and metabolic syndrome risk.
• Prompt earlier cardiovascular follow-up if NHR stays high alongside other risk factors.
• Interpret results most appropriate with a CBC differential, lipid panel, hs-CRP, and symptoms.

What is a Neutrophil-to-HDL Cholesterol Ratio (NHR) blood test?

Neutrophil-to-HDL Cholesterol Ratio (NHR) is a composite marker built from two routine blood measures: the number of neutrophils and the level of HDL cholesterol. Neutrophils are frontline white blood cells made in the bone marrow that surge during innate immune responses (neutrophils; innate immunity). HDL is a circulating particle formed mainly in the liver and intestine that ferries cholesterol away from tissues and carries antioxidant and anti-inflammatory proteins (high-density lipoprotein cholesterol; HDL-C). NHR simply relates these two signals from the same blood sample.

What it reflects is the body’s balance between inflammatory drive and protective lipid transport. Higher neutrophil activity signals acute inflammatory tone, while HDL supports cholesterol removal from artery walls (reverse cholesterol transport; RCT), tempers oxidative stress, and helps maintain the vessel lining (endothelial function). By linking these opposing forces, NHR captures the interplay between immune activation and vascular protection that underlies processes like plaque formation (atherogenesis) and tissue repair. In short, NHR offers a compact snapshot of how your immune system’s “go” signal compares with your HDL’s “guardrail” capacity at a given moment.

Why is a Neutrophil-to-HDL Cholesterol Ratio (NHR) blood test important?

The neutrophil‑to‑HDL cholesterol ratio (NHR) blends two powerful signals: how activated your innate immune system is (neutrophils) and how strong your anti‑inflammatory, cholesterol‑clearing capacity is (HDL). As a systems marker, it links inflammation, lipid handling, and vascular health, helping flag cardiometabolic and liver stress before disease is obvious.

There is no universal reference interval, but values typically sit in the lower single digits. In general, lower is considered more favorable because it reflects quieter inflammation and robust HDL function. When low because HDL is strong and neutrophils are normal, it aligns with resilient endothelial function and stable plaques. When low because neutrophils are suppressed (neutropenia), it can mean vulnerability to infections, with possible mouth ulcers, recurrent fevers, and slow wound healing—an immune, not lipid, issue.

Higher values usually indicate heightened inflammatory drive, lower HDL function, or both. This state promotes endothelial activation, stickier blood vessels, insulin resistance, and fat buildup in the liver (metabolic‑dysmetabolic signaling), often without symptoms. It commonly travels with abdominal adiposity, higher triglycerides, and elevated blood pressure. Men often have higher NHR than premenopausal women due to lower HDL. Pregnancy naturally raises neutrophils and can shift HDL, so NHR may rise physiologically. In children and teens, age‑specific blood count norms matter for interpretation.

Big picture, NHR sits at the crossroads of immunity and metabolism. Tracked alongside HDL, triglycerides, neutrophil count, hs‑CRP, A1c, and liver enzymes, it helps gauge long‑term risk for atherosclerotic disease, fatty liver, and metabolic dysfunction—and how effectively the body is balancing inflammation with repair.

What insights will I get?

The Neutrophil-to-HDL Cholesterol Ratio (NHR) compares first-responder immune cells (neutrophils) to the “scavenger” cholesterol carrier (HDL). It captures the balance between innate immune activation and HDL’s anti-inflammatory, reverse-cholesterol transport functions. Higher NHR has been associated with vascular inflammation, atherosclerosis, insulin resistance, fatty liver, and adverse cardiovascular outcomes.

Low values usually reflect fewer circulating neutrophils and/or higher HDL, indicating lower inflammatory tone and efficient cholesterol clearance. This pattern often aligns with better endothelial function, metabolic flexibility, and stable brain–vascular coupling. NHR tends to be lower in children, adolescents, and premenopausal women due to higher HDL. When low because neutrophils are truly reduced (neutropenia), susceptibility to bacterial infection increases.

Being in range suggests balanced immune–lipid signaling, supporting steady vascular function, glucose handling, and tissue repair without excess inflammation. In population studies, lower values within the laboratory range generally track with more favorable cardiometabolic profiles, but there is no universal target.

High values usually reflect more neutrophils and/or lower HDL, signaling systemic inflammation and diminished HDL anti-inflammatory capacity. This is common with acute infection, chronic inflammatory conditions, obesity-related insulin resistance, and smoking. Men and older adults often show higher ratios because HDL tends to be lower. Observational data link high NHR to greater coronary plaque burden, stroke risk, and nonalcoholic fatty liver disease.

Notes: Acute illness, stress, vigorous exercise, corticosteroids, and colony-stimulating factors raise neutrophils. HDL varies with illness, estrogen status, and assay method; fasting has minimal impact. Pregnancy increases neutrophils and alters HDL across trimesters, so gestation-specific interpretation is preferred. There are no standardized cutoffs; use lab-specific ranges and clinical context.